Upregulation of SPAG6 in Myelodysplastic Syndrome: Knockdown Inhibits Cell Proliferation via AKT/FOXO Signaling Pathway
Authors:
- 1 May 2019
- journal article
- research article
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 38 (5) , 476-484
Abstract
Recently, sperm-associated antigen 6 (SPAG6), a member of the cancer-testis antigen family, has been shown to be involved in tumorigenesis. An increasing number of studies have shown that SPAG6 expression is associated with the pathogenesis of myelodysplastic syndrome (MDS). However, the mechanism has not been clearly elucidated. Our previous results indicated that SPAG6 affected cell apoptosis in MDS. In this study, we used reverse transcription–quantitative polymerase chain reaction (RT–qPCR) to demonstrate that the mRNA expression of SPAG6 in bone marrow cells of patients with MDS or MDS-derived acute myeloid leukemia (MDS-AML) was higher than that of cancer-free patients. Kaplan–Meier survival curve analysis of published AML found that patients with high expression of SPAG6 had poor survival. The results of the cell counting kit-8, FACS, RT–qPCR, and Western blotting assays indicated that SPAG6 knockdown in the SKM-1 cell line inhibited cell proliferation, and affected cell cycle and differentiation. Furthermore, we found that SPAG6 knockdown affected the proliferation of SKM-1 cells by mediating the G1-to-S transition of the cell cycle. Moreover, we demonstrated that the antiproliferative effect of SPAG6 knockdown was associated with the upregulation of the cyclin-dependent kinase inhibitor p27Kip1, and regulation of the AKT/FOXO pathway. These findings indicated that SPAG6 might be a potential therapeutic target.Keywords
This publication has 32 references indexed in Scilit:
- Sperm-associated Antigens as Targets for Cancer ImmunotherapyJournal of Immunotherapy, 2011
- Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancerJournal of Molecular Signaling, 2010
- CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axisOncogene, 2010
- FOXOs, cancer and regulation of apoptosisOncogene, 2008
- Gene expression profiling of CD34+ cells in patients with the 5q− syndromeBritish Journal of Haematology, 2007
- Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypesCancer, 2007
- Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancerExperimental Gerontology, 2006
- Antigen‐specific immunotherapy and cancer vaccinesInternational Journal of Cancer, 2003
- cDNA Cloning and Characterization of a Human Sperm Antigen (SPAG6) with Homology to the Product of the Chlamydomonas PF16 LocusGenomics, 1999
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994